Medicines
SmPC of the 08/06/2026
PASSEDYL CHILDREN AND INFANTS, syrup
Composition
Sulfoguaiacol................................................................................................................................................ 1,174 g
Sodium benzoate...................................................................................................................................2,268 g
For 100 mL of syrup.
Excipients with known effect: sodium methyl parahydroxybenzoate (E219) (6,3 mg per 5 mL dose), sucrose (3,1 g per 5 mL dose), ethanol (150 mg per 5 mL dose), propylene glycol (E1520).
Tincture of Grindelia, concentrated extract for Tolu syrup, concentrated extract for Polygala syrup, natural orange flower flavouring*, sodium methyl parahydroxybenzoate (E219), caramel flavouring**, citric acid monohydrate, sucrose solution, purified water.
*Composition of the natural orange flower flavouring : Neroli essential oil, orange flower water, ethanol, linalool.
**Composition of caramel flavouring : flavouring preparations, flavouring substances, natural flavouring substances, propylene glycol (E1520), ethanol.
Dosage and administration
Oral use.
Infant and child under 5 years: 1 oral syringe filled up to the 5 mL graduation mark, 2 to 3 times a day.
Child over 5 years: 1 oral syringe filled up to the 5 mL graduation mark, 3 to 5 times a day.
Contraindications
History of hypersensitivity to any of the constituents (in particular to sodium benzoate, sodium methyl parahydroxybenzoate (E219).
Warnings and precautions
Special warnings
In case of greasy, purulent expectoration, in case of fever or in case of chronic bronchial and lung disease, re-examine the clinical situation.
Productive coughs, which are a fundamental element of bronchopulmonary defence, should be preserved.
The combination of bronchial mucomodifiers with antitussives and/or secretion-drying substances (antimuscarinics) is irrational.
The indication does not justify prolonged treatment.
Precautions for use
Caution is recommended in subjects with gastroduodenal ulcer.
This medicine contains sodium methyl parahydroxybenzoate (E219) which may cause allergic reactions (possibly delayed).
This medicine contains 3,1 g of sucrose per 5 mL of syrup. This should be taken into account for patients with diabetes mellitus.
Patients with fructose intolerance, glucose-galactose malabsorption syndrome or sucrase/isomaltase deficiency (rare hereditary diseases) must not take this medicine.
This medicine contains 150 mg of alcohol (ethanol) per 5 mL of syrup. The amount in 5 mL of this medicine is equivalent to 4 mL of beer or 2 mL of wine.
A dose of 5 taken of 5 mL of this medicine administered to a child over 5 years weighing 20 kg would result in an exposure to 37,5 mg/kg of ethanol likely to cause an increase in blood alcohol of about 2 mg/100 mL. For comparison, for an adult drinking a glass of wine or 500 mL of beer, the blood alcohol level should be about 50 mg/100 mL.
Co-administration of medicines containing, for example, propylene glycol or ethanol may lead to accumulation of ethanol and induce adverse effects, particularly in young children with low or immature metabolic capacity.
Interactions
The data available to date do not suggest the existence of clinically significant interactions.
Fertility, pregnancy and breastfeeding
Use with caution in pregnant or breastfeeding women, due to a lack of usable clinical data.
Driving and using machines
No effect on the ability to drive vehicles or use machines has been observed.
Adverse effects
Possibility of digestive disorders (nausea, vomiting).
Hypersensitivity reactions.
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Centres of Pharmacovigilance - Website: https://signalement.social-sante.gouv.fr/.
SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING
To open the bottle, Press firmly on the sides of the cap while turning it.
The vial must be closed again after each use.
The dose to be administered for one intake is obtained by pulling the plunger up to the 5 mL graduation. The dose is read at the flange of the syringe.
The use of the syringe for oral administration is strictly reserved for administering PASSEDYL CHILDREN AND INFANTS syrup.
The oral syringe must be rinsed after each use. Do not let it soak in the bottle.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
12 RUE DAUPHINE
21000 DIJON
Tel: 03 80 54 50 00 https://urgo.fr/
Source: VIDAL · Updated on 11/11/2026. This information does not replace advice from a healthcare professional.